Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BSEM Relative to the S&P 500

BSEM Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the BioStem Technologies Inc. (OTCMKT:BSEM) seasonal charts above shows that a Buy Date of October 11 and a Sell Date of February 2 has resulted in a geometric average return of 126.81% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 75.97% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.

To download BSEM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BSEM